These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 18223497)

  • 1. Use of pH-impedance testing to evaluate patients with suspected extraesophageal manifestations of gastroesophageal reflux disease.
    Malhotra A; Freston JW; Aziz K
    J Clin Gastroenterol; 2008 Mar; 42(3):271-8. PubMed ID: 18223497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of intraluminal impedance in patients with gastroesophageal reflux disease-like symptoms but normal endoscopy and 24-hour pH testing.
    Kline MM; Ewing M; Simpson N; Laine L
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):880-5; quiz 836. PubMed ID: 18424190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multichannel intraluminal impedance and pH-metry for investigation of symptomatic gastroesophageal reflux disease.
    Weigt J; Mönkemüller K; Peitz U; Malfertheiner P
    Dig Dis; 2007; 25(3):179-82. PubMed ID: 17827936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroesophageal reflux monitoring: pH (catheter and capsule) and impedance.
    Hong SK; Vaezi MF
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):1-22, v. PubMed ID: 19232277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy.
    Zerbib F; Roman S; Ropert A; des Varannes SB; Pouderoux P; Chaput U; Mion F; Vérin E; Galmiche JP; Sifrim D
    Am J Gastroenterol; 2006 Sep; 101(9):1956-63. PubMed ID: 16848801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of esophageal pH and multichannel intraluminal impedance testing in pediatric patients with suspected gastroesophageal reflux.
    Francavilla R; Magistà AM; Bucci N; Villirillo A; Boscarelli G; Mappa L; Leone G; Fico S; Castellaneta S; Indrio F; Lionetti E; Moramarco F; Cavallo L
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):154-60. PubMed ID: 19680154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent pneumonia from severe nonacid reflux: a case report and discussion.
    Malhotra A; Freston JW; Soriano M; Aziz K
    Conn Med; 2007 Aug; 71(7):403-5. PubMed ID: 17879862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined multichannel intraluminal impedance and pH esophageal testing compared to pH alone for diagnosing both acid and weakly acidic gastroesophageal reflux.
    Hila A; Agrawal A; Castell DO
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):172-7. PubMed ID: 17296528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is impedance pH monitoring superior to the conventional 24-h pH meter in the evaluation of patients with laryngorespiratory symptoms suspected to be due to gastroesophageal reflux disease?
    Ang D; Ang TL; Teo EK; Hsu PP; Tee A; Poh CH; Tan J; Ong J; Fock KM
    J Dig Dis; 2011 Oct; 12(5):341-8. PubMed ID: 21955426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of multichannel intraluminal impedance in the evaluation of children with persistent respiratory symptoms.
    Rosen R; Nurko S
    Am J Gastroenterol; 2004 Dec; 99(12):2452-8. PubMed ID: 15571595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: complete gastro-oesophageal reflux monitoring - combined pH and impedance.
    Tutuian R; Castell DO
    Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 2():27-37. PubMed ID: 16939430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy.
    Savarino E; Zentilin P; Tutuian R; Pohl D; Casa DD; Frazzoni M; Cestari R; Savarino V
    Am J Gastroenterol; 2008 Nov; 103(11):2685-93. PubMed ID: 18775017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of gastroesophageal reflux in pediatric patients with asthma using impedance-pH monitoring.
    Condino AA; Sondheimer J; Pan Z; Gralla J; Perry D; O'Connor JA
    J Pediatr; 2006 Aug; 149(2):216-9. PubMed ID: 16887437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraesophageal manifestations of gastroesophageal reflux disease: real or imagined?
    Moore JM; Vaezi MF
    Curr Opin Gastroenterol; 2010 Jul; 26(4):389-94. PubMed ID: 20473157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical importance of impedance measurements.
    Agrawal A; Castell DO
    J Clin Gastroenterol; 2008; 42(5):579-83. PubMed ID: 18364586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reflux monitoring: role of combined multichannel intraluminal impedance and pH.
    Tutuian R; Castell DO
    Gastrointest Endosc Clin N Am; 2005 Apr; 15(2):361-71. PubMed ID: 15722247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease.
    Vela MF
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):665-72. PubMed ID: 19072344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.